Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Alpha Thalassemia market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Alpha Thalassemiamarket, defines the market attractiveness level of Alpha Thalassemia market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Alpha Thalassemia industry, describes the types of Alpha Thalassemia market, the applications of major players and the market size, and deeply analyzes the current situation of the global Alpha Thalassemia market and the development prospects and opportunities of Alpha Thalassemia industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Alpha Thalassemia market in Chapter 13.
By Player:
Novartis
Bluebird Bio
Kiadis Pharma
Acceleron Pharma
By Type:
Iron Chelating Drugs
Gene Therapy
By End-User:
Hospitals
Private clinics
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Alpha Thalassemia Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Alpha Thalassemia Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Alpha Thalassemia Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Alpha Thalassemia Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Alpha Thalassemia Market Analysis and Outlook to 2022
-
7.1 Global Alpha Thalassemia Consumption (2017-2022)
-
7.2 United States Alpha Thalassemia Consumption (2017-2022)
-
7.3 Europe Alpha Thalassemia Consumption (2017-2022)
-
7.4 China Alpha Thalassemia Consumption (2017-2022)
-
7.5 Japan Alpha Thalassemia Consumption (2017-2022)
-
7.6 India Alpha Thalassemia Consumption (2017-2022)
-
7.7 South Korea Alpha Thalassemia Consumption (2017-2022)
8 Region and Country-wise Alpha Thalassemia Market Analysis and Outlook to 2028
-
8.1 Global Alpha Thalassemia Consumption Forecast (2022-2028)
-
8.2 United States Alpha Thalassemia Consumption Forecast (2022-2028)
-
8.3 Europe Alpha Thalassemia Consumption Forecast (2022-2028)
-
8.4 China Alpha Thalassemia Consumption Forecast (2022-2028)
-
8.5 Japan Alpha Thalassemia Consumption Forecast (2022-2028)
-
8.6 India Alpha Thalassemia Consumption Forecast (2022-2028)
-
8.7 South Korea Alpha Thalassemia Consumption Forecast (2022-2028)
9 Global Alpha Thalassemia Market Outlook by Types and Applications to 2022
-
9.1 Global Alpha Thalassemia Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Iron Chelating Drugs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Gene Therapy Consumption and Growth Rate (2017-2022)
-
9.2 Global Alpha Thalassemia Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Private clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Alpha Thalassemia Market Outlook by Types and Applications to 2028
-
10.1 Global Alpha Thalassemia Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Iron Chelating Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Alpha Thalassemia Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Private clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Alpha Thalassemia Import and Export Analysis (Top 5 Countries)
-
11.1 Global Alpha Thalassemia Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Alpha Thalassemia Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Alpha Thalassemia Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Alpha Thalassemia Market Competitive Analysis
-
14.1 Novartis
-
14.1.1 Novartis Company Details
-
14.1.2 Novartis Alpha Thalassemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis Alpha Thalassemia Product and Service
-
14.2 Bluebird Bio
-
14.2.1 Bluebird Bio Company Details
-
14.2.2 Bluebird Bio Alpha Thalassemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bluebird Bio Alpha Thalassemia Product and Service
-
14.3 Kiadis Pharma
-
14.3.1 Kiadis Pharma Company Details
-
14.3.2 Kiadis Pharma Alpha Thalassemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Kiadis Pharma Alpha Thalassemia Product and Service
-
14.4 Acceleron Pharma
-
14.4.1 Acceleron Pharma Company Details
-
14.4.2 Acceleron Pharma Alpha Thalassemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Acceleron Pharma Alpha Thalassemia Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Alpha Thalassemia
-
Figure Alpha Thalassemia Picture
-
Table Global Alpha Thalassemia Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Alpha Thalassemia Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Alpha Thalassemia Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Alpha Thalassemia Consumption by Country (2017-2022)
-
Figure United States Alpha Thalassemia Consumption and Growth Rate (2017-2022)
-
Table Europe Alpha Thalassemia Consumption and Growth Rate (2017-2022)
-
Figure China Alpha Thalassemia Consumption and Growth Rate (2017-2022)
-
Figure Japan Alpha Thalassemia Consumption and Growth Rate (2017-2022)
-
Figure India Alpha Thalassemia Consumption and Growth Rate (2017-2022)
-
Figure South Korea Alpha Thalassemia Consumption and Growth Rate (2017-2022)
-
Figure Global Alpha Thalassemia Consumption Forecast by Country (2022-2028)
-
Figure United States Alpha Thalassemia Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Alpha Thalassemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Alpha Thalassemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Alpha Thalassemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Alpha Thalassemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Alpha Thalassemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Iron Chelating Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Private clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Iron Chelating Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Private clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Alpha Thalassemia Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Alpha Thalassemia Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Alpha Thalassemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Alpha Thalassemia Product and Service
-
Table Bluebird Bio (Foundation Year, Company Profile and etc.)
-
Table Bluebird Bio Alpha Thalassemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bluebird Bio Alpha Thalassemia Product and Service
-
Table Kiadis Pharma (Foundation Year, Company Profile and etc.)
-
Table Kiadis Pharma Alpha Thalassemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kiadis Pharma Alpha Thalassemia Product and Service
-
Table Acceleron Pharma (Foundation Year, Company Profile and etc.)
-
Table Acceleron Pharma Alpha Thalassemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table Acceleron Pharma Alpha Thalassemia Product and Service
-
